Jesse J Salk
Principal investigator.
Medtech
Built from public records only: federal awards, patents, filings and papers.Is this you? Contact Noair Lab to claim this profile, correct it or hide it.
2018First federal award
$4.5MFederal grants as PI8 awards
4Patents grantedLatest Jul 14, 2026
0PapersOpenAlex
Federal awards and patents by year
AwardsPatents
8 awards · $4.5M
| Date | Agency | Award | Amount | Company |
|---|---|---|---|---|
| Jul 20, 2021 | NIH | SBIR Phase II Development of a Genotoxicity Assay using Duplex Sequencing | $620K | TWINSTRAND BIOSCIENCES INC |
| Jan 13, 2021 | NIH | SBIR Phase II Development of a Universal Assay for Minimal Residual Disease in Acute Myeloid Leukemia using Duplex Sequencing | $860K | TWINSTRAND BIOSCIENCES INC |
| Aug 20, 2020 | NIH | SBIR Phase II Development of a Genotoxicity Assay using Duplex Sequencing | $874K | TWINSTRAND BIOSCIENCES INC |
| Aug 13, 2020 | NIH | SBIR Phase II Early Detection of Ovarian Cancer Using Uterine Lavage and Duplex Sequencing | $222K | TWINSTRAND BIOSCIENCES INC |
| Dec 23, 2019 | NIH | SBIR Phase II Development of a Universal Assay for Minimal Residual Disease in Acute Myeloid Leukemia using Duplex Sequencing | $690K | TWINSTRAND BIOSCIENCES INC |
| Jul 11, 2019 | NIH | SBIR Phase II Development of a Genotoxicity Assay using Duplex Sequencing | $225K | TWINSTRAND BIOSCIENCES INC |
| May 2, 2019 | NIH | SBIR Phase II Development of a Universal Assay for Minimal Residual Disease in Acute Myeloid Leukemia using Duplex Sequencing | $690K | TWINSTRAND BIOSCIENCES INC |
| Jul 16, 2018 | NIH | SBIR Phase II Development of a Universal Assay for Minimal Residual Disease in Acute Myeloid Leukemia using Duplex Sequencing | $300K | TWINSTRAND BIOSCIENCES INC |
5 patents as inventor
- US 11739367TWINSTRAND BIOSCIENCES INCAug 29, 2023
- US 11845985TWINSTRAND BIOSCIENCES INCDec 19, 2023
- US 12529101TWINSTRAND BIOSCIENCES INCJan 20, 2026
- US 12680131TWINSTRAND BIOSCIENCES INCJul 14, 2026
- US TWINSTRAND BIOSCIENCES INC—
Matched by the first inventor’s name and the patent’s company.
Peer ranks
Federal funding#351
Awards as PI#216
Patents#89
Companies
- TWINSTRAND BIOSCIENCES INCLinked by awards · Medtech
Federal awards through Oct 21, 2026 and patents through Oct 20, 2026. Awards come from NIH, NSF and other agency records that name a principal investigator; DoD and NASA contract awards do not, so they are not shown here. Researchers are matched by name and company.